Analysis of consumer comments into PBAC decision-making (2014-9)
Emily Tjeuw1, Michael J Wonder1
1Wonder Drug Consulting, PO Box 470, Cronulla, New South Wales2230, Australia.
International Journal of Technology Assessment in Health Care
|February 4, 2022
Summary
Most health technology assessments lack consumer comments, with few receiving substantial input. Improvements are needed to enhance consumer engagement in the Pharmaceutical Benefits Advisory Committee (PBAC) process.
Area of Science:
- Health Technology Assessment
- Pharmaceutical Policy
- Consumer Engagement
Background:
- The Pharmaceutical Benefits Advisory Committee (PBAC) evaluates new health technologies for the Pharmaceutical Benefits Scheme.
- Since 2014, PBAC has incorporated consumer comments via an online portal into its evidence-based decision-making.
- Public Summary Documents (PSDs) report on received consumer comments.
Purpose of the Study:
- To analyze and review the utilization and impact of consumer comments in the PBAC's decision-making process.
- To identify limitations in the current consumer comments system.
- To propose improvements for enhanced consumer engagement.
Main Methods:
- Data extraction from PBAC Public Summary Documents (PSDs) between 2014 and 2019.
- Descriptive analysis of consumer comment data.
Main Results:
- Two-thirds of submissions received no consumer comments.
- Less than 1% of submissions (eight cases) garnered over 500 consumer comments, often requiring multiple submissions for PBAC recommendation.
- Therapeutic areas with the most comments included genetic diseases, pediatrics, and oncology.
Conclusions:
- The current consumer comments process has identified limitations.
- Improvements can be made by examining comparable health technology assessment agencies.
- Recommendations focus on increasing consumer engagement in PBAC evaluations.
More Related Videos
Related Concept Videos
01:09Decision Making: P-value Method
5.8K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
5.8K
01:12Analysis of Population Pharmacokinetic Data
419
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
419
01:19Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
01:14Decision Making: Traditional Method
4.3K
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
4.3K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
272
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
272
01:14SBAR II: Application of SBAR
4.9K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.9K